Skip to main content

Manufacturing

The past 25 years have seen a steady progression in business relationships between CDMOs and drug developers.

The initial focus of identifying supply chain inefficiencies has advanced from controlling fixed costs and capacity fluctuations to gaining access to specific technologies, skills, and/or scientific expertise not possessed in-house.

Our research helps drug innovators understand the dynamic drug manufacturing environment, identify the right type of outsourcing model to best meet their organizations’ needs, and make smarter CDMO selection decisions based on hard data collected from outsourcing peers.

CDMOs benefit from understanding the competitive landscape, outsourcing drivers, CDMO selection criteria, and the decision-making process. Additionally, our reports provide insight into potential changes in demand for CDMO services and ways service providers could better meet the needs of drug developers.

manufacturing category

Major Topics:

  • Biologics
  • CDMO Outsourcing Models
  • Cell Therapies
  • Clinical Manufacturing
  • Gene Therapies
  • Oral Dosage Forms
  • Small Molecules, including HPAPI
  • Sterile Injectables
  • Supply Chain & Logistics

Types of Manufacturing Reports

Market Outlook

Outsourcing Models

Service Provider Performance

Recent Manufacturing Reports

Insights into CDMO Selection from the External Manufacturing Department

Insights into CDMO Selection from the External Manufacturing Department

View Report
Small Molecule Drug Product CDMO Benchmarking (7th Ed.)

Small Molecule Drug Product CDMO Benchmarking (7th Ed.)

View Report
Navigating Cell Therapy Supply Chain Challenges

Navigating Cell Therapy Supply Chain Challenges

View Report
Biologic Drug Product CDMO Benchmarking (7th Ed.)

Biologic Drug Product CDMO Benchmarking (7th Ed.)

View Report

Interested in more of our manufacturing market research?

View Library

Industry Articles – Manufacturing